- Stage
- In committee
- Started in
- House
- Sponsors
- 8
- Latest action
- Jun 4, 2026
What it does
The PKD Cures Act aims to advance research on polycystic kidney disease (PKD) by expanding and intensifying NIH-funded research into its genetic, molecular, and clinical aspects, including basic, translational, and clinical studies. It requires the NIH Director to collaborate with federal agencies, academic institutions, private sector stakeholders, and patient advocacy groups to accelerate treatment development and support specialized training for researchers and clinicians. The bill also mandates the creation of a comprehensive PKD research roadmap by a NIH-appointed working group, which must identify research gaps, recommend collaboration strategies, propose timelines for milestones, and…
No official summary is available here. This one was written by AI from the bill’s text.
Where it stands
Introduced (Done)
Committee (Current step)
Floor (Not started)
Law (Not started)
What moved
Who is involved
Sponsors
The lawmakers who put their names on it, lead sponsors first.
Where it goes next
While a bill can still move, the questions are about people and money.